1. Home
  2. ZLAB vs VEON Comparison

ZLAB vs VEON Comparison

Compare ZLAB & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • VEON
  • Stock Information
  • Founded
  • ZLAB 2013
  • VEON 1992
  • Country
  • ZLAB China
  • VEON United Arab Emirates
  • Employees
  • ZLAB N/A
  • VEON N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • ZLAB Health Care
  • VEON Telecommunications
  • Exchange
  • ZLAB Nasdaq
  • VEON Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • VEON 3.9B
  • IPO Year
  • ZLAB 2017
  • VEON 1996
  • Fundamental
  • Price
  • ZLAB $30.14
  • VEON $52.95
  • Analyst Decision
  • ZLAB Buy
  • VEON Strong Buy
  • Analyst Count
  • ZLAB 4
  • VEON 1
  • Target Price
  • ZLAB $47.37
  • VEON $60.00
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • VEON 264.7K
  • Earning Date
  • ZLAB 05-08-2025
  • VEON 05-15-2025
  • Dividend Yield
  • ZLAB N/A
  • VEON N/A
  • EPS Growth
  • ZLAB N/A
  • VEON N/A
  • EPS
  • ZLAB N/A
  • VEON 6.24
  • Revenue
  • ZLAB $418,326,000.00
  • VEON $4,088,000,000.00
  • Revenue This Year
  • ZLAB $44.07
  • VEON $5.99
  • Revenue Next Year
  • ZLAB $49.13
  • VEON $7.19
  • P/E Ratio
  • ZLAB N/A
  • VEON $8.49
  • Revenue Growth
  • ZLAB 43.72
  • VEON 8.84
  • 52 Week Low
  • ZLAB $16.01
  • VEON $25.20
  • 52 Week High
  • ZLAB $39.77
  • VEON $58.30
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.27
  • VEON 57.85
  • Support Level
  • ZLAB $30.11
  • VEON $52.85
  • Resistance Level
  • ZLAB $31.34
  • VEON $54.99
  • Average True Range (ATR)
  • ZLAB 1.09
  • VEON 2.68
  • MACD
  • ZLAB 0.07
  • VEON -0.18
  • Stochastic Oscillator
  • ZLAB 43.07
  • VEON 45.52

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: